The purpose of this position is the review of executed batch records, analytical results and other GMP documentation for accuracy, completeness, and conformance to established documentation standards, including disposition of starting materials, in process and finished products. This position ensures that all specifications are met at each stage of manufacturing and prior to final product release to comply with FDA and cGMP regulatory requirements. The scope of support includes review of batch records and analytical results for product complaint investigations and Product Development activities and serves on assigned internal projects as a technical/compliance resource to solve quality issues.
Competencies:
Education / Experience:
BS degree or technical equivalent / Three to five years of professional experience in pharmaceutical industry and Product Release. PC literate with basic knowledge of application software. Understanding of internal SOPs, FDA guidelines (CFRs), and cGMP regulations. Experience with MES e-Batch Record system, JDE ERP system and TrackWise is a plus.
Judgment / Decision Making:
Duties are performed under general direction within a framework of established and routine guidelines; some modification and interpretation required.
Work Environment:
Air-conditioned office environment.
Physical Demands:
Visual acuity and manual dexterity required to review documents and operate computers.

Noven Pharmaceuticals, Inc. is a dynamic specialty pharmaceutical company engaged in the research, development, manufacture, marketing and sale of prescription pharmaceutical products. We are committed to developing and offering pharmaceutical products that meaningfully benefit patients, with a commitment to advancing patient care through transdermal drug delivery.
Over 300 Noven colleagues are working to advance our business and benefit patients at locations in Miami, FL, Jersey City, NJ. We are a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., the world’s largest manufacturer of transdermal patches, and we serve as Hisamitsu's growth platform for U.S. prescription pharmaceuticals.
Noven maintains state-of-the art, FDA-approved transdermal manufacturing facilities in Miami with capacity to produce several hundred million patches per year. These facilities are also approved by the U.S. DEA (Drug Enforcement Agency) for the production of controlled substances.